Top

Published in:

18-04-2022 | Dementia | Original Article

How long does it take to diagnose young-onset dementia? A comparison with late-onset dementia

Authors: A. Chiari, M. Tondelli, C. Galli, C. Carbone, L. Fiondella, S. Salemme, G. Vinceti, R. Bedin, M. A. Molinari, G. Zamboni

Published in: Neurological Sciences | Issue 8/2022

Abstract

Introduction

Dementia occurring in young people may be difficult to recognize. We compared the time to diagnosis between young- (YOD, age < 65) and late-onset dementia (LOD).

Methods

Time between the onset of symptoms and the diagnosis was measured in YOD and LOD patients consecutively seen in a cognitive neurology clinic. Multivariable regression analyses were performed to identify determinants of time to diagnosis.

Results

Mean time to diagnosis in 95 YOD patients was 11.2 months longer than in 73 LOD patients (p = 0.022). The delay was driven by a longer time taken by YOD patients to be seen in the specialist centre, which in turn was related to the presence of language disturbances and coexisting depression.

Discussion

Young people take longer than elderly people to receive a dementia diagnosis because they take longer to be referred to dementia specialist centres. More awareness on YOD is needed in primary care and the public.

van de Veen D, Bakker C, Peetoom K, Pijnenburg Y, Papma JM, Group PS et al (2021) An integrative literature review on the nomenclature and definition of dementia at a young age. J Alzheimers Dis 83:1891–916CrossRef

Chiari A, Vinceti G, Adani G, Tondelli M, Galli C, Fiondella L et al (2021) Epidemiology of early onset dementia and its clinical presentations in the province of Modena. Italy Alzheimers Dement 17:81–88CrossRef

Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD (2010) The diagnosis of young-onset dementia. Lancet Neurol 9:793–806CrossRef

van Vliet D, de Vugt ME, Bakker C, Pijnenburg YA, Vernooij-Dassen MJ, Koopmans RT et al (2013) Time to diagnosis in young-onset dementia as compared with late-onset dementia. Psychol Med 43:423–432CrossRef

Graff-Radford J, Yong KXX, Apostolova LG, Bouwman FH, Carrillo M, Dickerson BC et al (2021) New insights into atypical Alzheimer’s disease in the era of biomarkers. Lancet Neurol 20:222–234CrossRef

Apostolova LG Aisen P Eloyan A Fagan A Fargo KN Foroud T et al. 2021 The Longitudinal Early-onset Alzheimer’s Disease Study (LEADS): framework and methodology. Alzheimer’s Dement.

Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM et al (2017) Consensus classification of posterior cortical atrophy. Alzheimers Dement 13:870–884CrossRef

Ossenkoppele R, Pijnenburg YA, Perry DC, Cohn-Sheehy BI, Scheltens NM, Vogel JW et al (2015) The behavioural/dysexecutive variant of Alzheimer’s disease: clinical, neuroimaging and pathological features. Brain J neurol 138:2732–2749CrossRef

Carter JE, Oyebode JR, Koopmans R (2018) Young-onset dementia and the need for specialist care: a national and international perspective. Aging Ment Health 22:468–473CrossRef

10.

Loi SM Goh AMY Mocellin R Malpas CB Parker S Eratne D et al. 2020 Time to diagnosis in younger-onset dementia and the impact of a specialist diagnostic service. International psychogeriatrics / IPA:1–9.

11.

McKhann GM, Knopman DS, Chertkow H, Hyman BT, Jack CR Jr, Kawas CH et al (2011) The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement 7:263–269CrossRef

12.

Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC et al (2011) The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s Dement 7:270–279CrossRef

13.

Skrobot OA, O’Brien J, Black S, Chen C, DeCarli C, Erkinjuntti T et al (2017) The Vascular impairment of cognition classification consensus study. Alzheimer’s Dement 13:624–633CrossRef

14.

Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J et al (2011) Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain J neurol 134:2456–2477CrossRef

15.

Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF et al (2011) Classification of primary progressive aphasia and its variants. Neurology 76:1006–1014CrossRef

16.

McKeith IG, Boeve BF, Dickson DW, Halliday G, Taylor JP, Weintraub D et al (2017) Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology 89:88–100CrossRef

17.

Emre M Aarsland D Brown R Burn DJ Duyckaerts C Mizuno Y et al. 2007 Clinical diagnostic criteria for dementia associated with Parkinson’s disease. Mov Disord. 22:1689–707; quiz 837.

18.

Litvan I, Agid Y, Calne D, Campbell G, Dubois B, Duvoisin RC et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9CrossRef

19.

Armstrong MJ, Litvan I, Lang AE, Bak TH, Bhatia KP, Borroni B et al (2013) Criteria for the diagnosis of corticobasal degeneration. Neurology 80:496–503CrossRef

20.

Linn BS, Linn MW, Gurel L (1968) Cumulative illness rating scale. J Am Geriatr Soc 16:622–626CrossRef

21.

Draper B, Cations M, White F, Trollor J, Loy C, Brodaty H et al (2016) Time to diagnosis in young-onset dementia and its determinants: the INSPIRED study. Int J Geriatr Psychiatry 31:1217–1224CrossRef

22.

Kvello-Alme M, Brathen G, White LR, Sando SB (2021) Time to diagnosis in young onset Alzheimer’s disease: a population-based study from Central Norway. J Alzheimer’s Dis 82:965–974CrossRef

23.

Woolley JD, Khan BK, Murthy NK, Miller BL, Rankin KP (2011) The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry 72:126–133CrossRef

24.

van Vliet D, de Vugt ME, Bakker C, Koopmans RT, Pijnenburg YA, Vernooij-Dassen MJ et al (2011) Caregivers’ perspectives on the pre-diagnostic period in early onset dementia: a long and winding road. Int psychogeriatr Ipa 23:1393–1404CrossRef

25.

Chiari A, Pistoresi B, Galli C, Tondelli M, Vinceti G, Molinari MA et al (2021) Determinants of caregiver burden in early-onset dementia. Dement Geriatr Cogn Dis Extra 11:189–197CrossRef

26.

Albuquerque L, Valente ARS, Teixeira A, Figueiredo D, Sa-Couto P, Oliveira C (2021) Association between acoustic speech features and non-severe levels of anxiety and depression symptoms across lifespan. PloS one 16:e0248842CrossRef

27.

Jack CR Jr, Bennett DA, Blennow K, Carrillo MC, Dunn B, Haeberlein SB et al (2018) NIA-AA research framework: toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement 14:535–562CrossRef

Title: How long does it take to diagnose young-onset dementia? A comparison with late-onset dementia
Authors: A. Chiari
M. Tondelli
C. Galli
C. Carbone
L. Fiondella
S. Salemme
G. Vinceti
R. Bedin
M. A. Molinari
G. Zamboni
Publication date: 18-04-2022
Publisher: Springer International Publishing
Keywords: Dementia
Dementia
Published in: Neurological Sciences / Issue 8/2022
Print ISSN: 1590-1874
Electronic ISSN: 1590-3478
DOI: https://doi.org/10.1007/s10072-022-06056-1

Keynote webinar | Spotlight on medication adherence

Springer Medicine

How long does it take to diagnose young-onset dementia? A comparison with late-onset dementia

Abstract

Introduction

Methods

Results

Discussion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Introduction

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 8/2022

Is hypnotic assessment relevant to neurology?

Patient-reported outcome and cognitive measures to be used in vascular and brain tumor surgery: proposal for a minimum set

Long-term outcomes of ruptured saccular intracranial aneurysm clipping versus coiling: systematic review and meta-analysis of randomized controlled trials

Rasagiline, sleep quality and well-being in Parkinson’s disease: a pilot study

Pain in atypical parkinsonism, vascular parkinsonism, and Parkinson’s disease

The efficacy of combining topiramate and 4-aminopyridine to reduce relapses and interictal progression in two cases of episodic ataxia type 2